New Software Streamlines Interface Management with Better Security and Controls

New software enables the management of multiple hospital information systems (HIS) and device interfaces through a single, web-based console while providing increased system security and control for network administrators.

Lumedx Corp. (Oakland, CA, USA), a provider of fully integrated cardiovascular imaging and information systems, introduces the latest version of CardioGate interface management system. A major component of the CardioStar range of integrated imaging and information tools, CardioGate works to streamline workflow by importing data from all a hospital's best-of-breed devices and systems.

The CardioGate 3.1 software include features that (1) automates and simplifies the management of multiple interfaces with a single login; (2) facilitates the hosting of unattended servers, supporting information technology (IT) compliance; (3) allows system administrators to restrict user access based on database privileges and on a per-interface basis for better system security and control; (4) offers at-a-glance web page view of status of all interfaces and generates email alerts when problems occur; (5) improves interface management efficiency, reducing turnaround time for reports and billing.

"As heart and vascular programs evolve, devices, systems, and interfaces multiply,” said Lumedx technical program manager Tiana Thomas. "CardioGate 3.1 helps IT administrators by enabling remote, at-a-glance management of multiple interfaces. The result: constant, accurate monitoring of interface status, health, and activity.”

With over 500 heart center clients worldwide, Lumedx is a market leader in fully integrated cardiovascular information systems and cardiology and communication systems (PACS) solutions provider. The company's cardiovascular imaging and information systems play a critical role in helping healthcare systems meet many of current challenges and opportunities, including pay-for-performance, evidence-based medicine, greater competition and transparency in the marketplace, and new governmental regulations.

Related Links:
Lumedx